Julia Jabs

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 2

Top Topics

Squamous Cell Carcinoma

Dna Damage Response

Top Venues

Molecular cancer therapeutics

Molecular systems biology

This page only lists publications with an associated author ORCID identifier.

Publications

Manja Friese-Hamim, Maria J Ortiz-Ruiz, Olga Bogatyrova, Marina Keil, Felix Rohdich, Beatrix Blume, Birgitta Leuthner, Frank Czauderna, Diane Hahn, Julia Jabs, Frank Jaehrling, Timo Heinrich, Roland Kellner, Katherine Chan, Amy H Y Tong, Dirk Wienke, Jason Moffat, Andree Blaukat, Frank T Zenke
Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models. Molecular cancer therapeutics (2023)
Julia Jabs, Franziska Maria Zickgraf, Jeongbin Park, Steve Wagner, Xiaoqi Jiang, Katharina Jechow, Kortine Kleinheinz, Umut H Toprak, Marc A Schneider, Michael Meister, Saskia Spaich, Marc Sütterlin, Matthias Schlesner, Andreas Trumpp, Martin R Sprick, Roland Eils, Christian Conrad
Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations. Molecular systems biology 13 (11) (2017)